Haptena Therapeutics
Turin
About Haptena Therapeutics
Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
Company Facts
- Operating status: Active
- IPO status: Private
- Total funding: $3.5M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: haptena.com
Canonical: https://fsome.com/organization/haptena-therapeutics-79538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.